NZ208386A - 2-(n-(1-carboxyalkyl)alanyl isoindol-1-ylcarboxylic acids and pharmaceutical compositions - Google Patents

2-(n-(1-carboxyalkyl)alanyl isoindol-1-ylcarboxylic acids and pharmaceutical compositions

Info

Publication number
NZ208386A
NZ208386A NZ208386A NZ20838684A NZ208386A NZ 208386 A NZ208386 A NZ 208386A NZ 208386 A NZ208386 A NZ 208386A NZ 20838684 A NZ20838684 A NZ 20838684A NZ 208386 A NZ208386 A NZ 208386A
Authority
NZ
New Zealand
Prior art keywords
carbon atoms
formula
alkyl radical
see diagramm
compatible mineral
Prior art date
Application number
NZ208386A
Inventor
M Vincent
G Remond
M Laubie
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NZ208386A publication Critical patent/NZ208386A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Compounds corresponding to the general formula I : see diagramm : EP0129461,P7,F5 in which the ring A is saturated or, alternatively, benzenic, R represents a hydrogen atom or a lower alkyl group having from 1 to 4 carbon atoms, R' represents a linear alkyl radical having from 1 to 6 carbon atoms or a mono- or di-cycloalkyl-alkyl radical having from 4 to 7 carbon atoms, in their racemic form or in the form of optical isomers, and the salts thereof obtained with a therapeutically compatible mineral or organic base or the addition salts thereof obtained with a pharmaceutically compatible mineral or organic acid. 1. Claim for the contracting state : AT Process for the preparation of compounds corresponding to the general formula I : see diagramm : EP0129461,P7,F6 in which the ring A is saturated or, alternatively, benzenic, R represents a hydrogen atom or a lower alkyl group having from 1 to 4 carbon atoms, R' represents a linear alkyl radical having from 1 to 6 carbon atoms or a mono- or di-cycloalkyl-alkyl radical having from 4 to 7 carbon atoms, in their racemic form or in the form of optical isomers, and the salts thereof obtained with a therapeutically compatible mineral or organic base or the addition salts thereof obtained with a pharmaceutically compatible mineral or organic acid, characterised in that a carboxyisoindole derivative of the formula : see diagramm : EP0129461,P8,F1 in which A has the same meaning as in formula I and R" represents an alkyl group having from 1 to 6 carbon atoms, preferably a tert.-butyl group, or one of the addition salts thereof, is condensed with a functional derivative of a substituted amino acid of the formula III : see diagramm : EP0129461,P8,F2 in which R et R' have the same meanings as in formula I and the nitrogen atom is protected by a radical customarily used for protection in the synthesis of peptides, such as benzyloxycarbonyl or tert.-butoxycarbonyl, and the intermediate compound obtained is subjected to customary deprotecting processes, such as, for example, total or partial saponification, and/or hydrogenolysis, and in this manner is converted into a compound of the formula I.
NZ208386A 1983-06-06 1984-06-05 2-(n-(1-carboxyalkyl)alanyl isoindol-1-ylcarboxylic acids and pharmaceutical compositions NZ208386A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8309326A FR2546886B2 (en) 1983-06-06 1983-06-06 DERIVATIVES OF ISOINDOLEDICARBOXYLIC ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
NZ208386A true NZ208386A (en) 1989-01-27

Family

ID=9289500

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ208386A NZ208386A (en) 1983-06-06 1984-06-05 2-(n-(1-carboxyalkyl)alanyl isoindol-1-ylcarboxylic acids and pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0129461B1 (en)
JP (1) JPS6011467A (en)
AT (1) ATE25258T1 (en)
AU (1) AU566490B2 (en)
CA (1) CA1274347A (en)
DE (1) DE3462261D1 (en)
ES (1) ES8506623A1 (en)
FR (1) FR2546886B2 (en)
IE (1) IE57600B1 (en)
NZ (1) NZ208386A (en)
OA (1) OA07716A (en)
PT (1) PT78697A (en)
ZA (1) ZA844262B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000896A1 (en) * 1984-07-30 1986-02-13 Schering Corporation NOVEL PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA ADb BDPYRROLE-2-CARBOXYLATE
DE3640641A1 (en) * 1986-11-28 1988-07-14 Thomae Gmbh Dr K NEW HETEROAROMATIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
ES2307923T3 (en) 2003-02-28 2008-12-01 Les Laboratoires Servier S.A. PROCEDURE FOR PREPARATION OF PERINDOPRIL AND SALTS OF THE SAME.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487829A2 (en) * 1979-12-07 1982-02-05 Science Union & Cie NOVEL SUBSTITUTED IMINO ACIDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR
DE3177311D1 (en) * 1980-08-30 1994-06-09 Hoechst Ag Amino acid derivatives, processes for their preparation, compositions containing them and their use.
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
LU88621I2 (en) * 1980-10-23 1995-09-01 Schering Corp Sandopril
GB2086390B (en) * 1980-11-03 1984-06-06 Ciba Geigy Ag 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
JPS57158758A (en) * 1981-02-17 1982-09-30 Warner Lambert Co Substatuted acyl derivative of octahydro-1h- isoindole-1-carboxylic acid
EP0058567B1 (en) * 1981-02-17 1984-07-25 Warner-Lambert Company Substituted acyl derivatives of octahydro-1h-isoindole-1-carboxylic acids and esters
EP0081094A1 (en) * 1981-11-12 1983-06-15 Merck & Co. Inc. Substituted omega-amino-carboxymethyldipeptide antihypertensive agents
US4431644A (en) * 1982-03-08 1984-02-14 Schering Corporation Antihypertensive agents
DE3211676A1 (en) * 1982-03-30 1983-10-06 Hoechst Ag NEW DERIVATIVES OF CYCLOALKA (C) PYRROL CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF, THEIR SUBSTANCES AND THE USE THEREOF AND NEW CYCLOALKA (C) PYRROL CARBONIC ACIDS AS THE INTERMEDIATE LEVELS AND METHODS
DE3315464A1 (en) * 1983-04-28 1984-10-31 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING N-ALKYLATED DIPEPTIDES AND THEIR ESTERS

Also Published As

Publication number Publication date
FR2546886A2 (en) 1984-12-07
IE841386L (en) 1984-12-06
OA07716A (en) 1985-08-30
AU566490B2 (en) 1987-10-22
JPS6011467A (en) 1985-01-21
IE57600B1 (en) 1993-01-27
ATE25258T1 (en) 1987-02-15
EP0129461A1 (en) 1984-12-27
CA1274347A (en) 1990-09-18
ES533174A0 (en) 1985-08-01
ES8506623A1 (en) 1985-08-01
ZA844262B (en) 1985-01-30
AU2915184A (en) 1984-12-20
PT78697A (en) 1984-07-01
FR2546886B2 (en) 1986-05-16
EP0129461B1 (en) 1987-01-28
DE3462261D1 (en) 1987-03-05

Similar Documents

Publication Publication Date Title
PT76316B (en) Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect
GR3003598T3 (en)
ES8306160A1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds.
EP0237051A3 (en) Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
ES8503667A1 (en) 2-Oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
EP0293771A3 (en) Cephalosporin compound and pharmaceutical composition thereof
NZ208386A (en) 2-(n-(1-carboxyalkyl)alanyl isoindol-1-ylcarboxylic acids and pharmaceutical compositions
HUT36799A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them
YU45288B (en) Process for optical dividing of racemic mixtures of alpha-naphtil-propionic acids
NZ196159A (en) Crystalline 7 -(2-(2-amino-4-thiazolyl)-2-methoxy-iminoacetamido)-3-cephem-4-carboxylic acid pivaloyloxymethyl ester hydrochloride and hydrobromide and pharmaceutical compositions
ATE212637T1 (en) ANTIBIOTICALLY EFFECTIVE CEPHALOSPORINS AND METHOD FOR THE PRODUCTION THEREOF
GR3002416T3 (en) Derivatives of glutamic acid, their salts, process for their preparation, use as medicines and compositions containing them
PT89492A (en) PREPARATION PROCESS OF NEW THERAPEUTICALLY ACTIVE THIOFORMAMIDE DERIVATIVES
JPS5645451A (en) Novel peptideamide and its manufacture
GB1066266A (en) Diazepine derivatives
IL59284A0 (en) Dextrorotatory,basic derivative of 9,1/-ethanoanthracene and salts thereof,their preparation and pharmaceutical compositions containing them
ES8600762A1 (en) Beta-lactam compounds.
GB889660A (en) Morphanthridine compounds